Renaissance Pharma launches today and announces the in-licensing of Hu14.18K322A (Hu14.18) from St. Jude Children’s Research Hospital for the treatment of High-Risk Neuroblastoma
August 01, 2023 07:00 ET
|
Renaissance Pharma
Press Release Renaissance Pharma launches today and announces the in-licensing of Hu14.18K322A (Hu14.18) from St. Jude Children’s Research Hospital for the treatment of High-Risk Neuroblastoma ...
Renaissance Pharma launches today and announces the in-licensing of Hu14.18K322A (Hu14.18) from St. Jude Children’s Research Hospital for the treatment of High-Risk Neuroblastoma
August 01, 2023 03:00 ET
|
Renaissance Pharma
Press Release Renaissance Pharma launches today and announces the in-licensing of Hu14.18K322A (Hu14.18) from St. Jude Children’s Research Hospital for the treatment of High-Risk Neuroblastoma ...
St. Baldrick's Foundation Grants $21.2 Million for Lifesaving Research
July 16, 2015 09:15 ET
|
St. Baldrick's Foundation
LOS ANGELES, July 16, 2015 (GLOBE NEWSWIRE) -- The St. Baldrick's Foundation, a volunteer-powered charity dedicated to funding children's cancer research, is pleased to award 70 grants in 48 states...